1. Home
  2. ENSC vs HAO Comparison

ENSC vs HAO Comparison

Compare ENSC & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • HAO
  • Stock Information
  • Founded
  • ENSC 2003
  • HAO 2018
  • Country
  • ENSC United States
  • HAO China
  • Employees
  • ENSC N/A
  • HAO N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • ENSC Health Care
  • HAO
  • Exchange
  • ENSC Nasdaq
  • HAO NYSE
  • Market Cap
  • ENSC 3.4M
  • HAO 3.3M
  • IPO Year
  • ENSC N/A
  • HAO 2024
  • Fundamental
  • Price
  • ENSC $2.34
  • HAO $1.40
  • Analyst Decision
  • ENSC
  • HAO
  • Analyst Count
  • ENSC 0
  • HAO 0
  • Target Price
  • ENSC N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • ENSC 5.0M
  • HAO 42.4K
  • Earning Date
  • ENSC 05-13-2025
  • HAO 05-31-2025
  • Dividend Yield
  • ENSC N/A
  • HAO N/A
  • EPS Growth
  • ENSC N/A
  • HAO N/A
  • EPS
  • ENSC N/A
  • HAO 0.19
  • Revenue
  • ENSC $6,224,081.00
  • HAO $48,970,924.00
  • Revenue This Year
  • ENSC N/A
  • HAO N/A
  • Revenue Next Year
  • ENSC N/A
  • HAO N/A
  • P/E Ratio
  • ENSC N/A
  • HAO $7.63
  • Revenue Growth
  • ENSC 256.35
  • HAO 15.04
  • 52 Week Low
  • ENSC $1.62
  • HAO $0.09
  • 52 Week High
  • ENSC $14.67
  • HAO $8.81
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 46.40
  • HAO 49.52
  • Support Level
  • ENSC $1.99
  • HAO $1.37
  • Resistance Level
  • ENSC $2.40
  • HAO $1.70
  • Average True Range (ATR)
  • ENSC 0.26
  • HAO 0.19
  • MACD
  • ENSC 0.02
  • HAO 0.01
  • Stochastic Oscillator
  • ENSC 28.00
  • HAO 47.76

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: